IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19?
Saved in:
| Title: | IL-6 antagonists to replace systemic corticosteroids as the preferred anti-inflammatory therapy in patients with COVID-19? |
|---|---|
| Authors: | Kow CS; School of Postgraduate Studies, International Medical University, Kuala Lumpur, Malaysia; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia. Electronic address: chiasiang_93@hotmail.com., Zaihan AF; Department of Pharmacy, Shah Alam Hospital, Persiaran Kayangan, Seksyen 7, Shah Alam, Selangor, Malaysia., Ramachandram DS; School of Pharmacy, Monash University Malaysia, Jalan Lagoon Selatan, Bandar Sunway, Subang Jaya, Selangor, Malaysia., Hasan SS; School of Applied Sciences, University of Huddersfield, Huddersfield, United Kingdom; School of Biomedical Sciences & Pharmacy, University of Newcastle, Callaghan, Australia. |
| Source: | Cytokine [Cytokine] 2022 Jan; Vol. 149, pp. 155730. Date of Electronic Publication: 2021 Oct 05. |
| Publication Type: | Journal Article; Meta-Analysis |
| Journal Info: | Publisher: Elsevier Science Ltd Country of Publication: England NLM ID: 9005353 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0023 (Electronic) Linking ISSN: 10434666 NLM ISO Abbreviation: Cytokine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| ISSN: | 1096-0023 |
|---|---|
| DOI: | 10.1016/j.cyto.2021.155730 |
